Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 73 to 77 of 77 entries
Sorted by: Best Match Show Resources per page
Machine learning applications in tobacco research: a scoping review.

Tobacco control

Fu R, Kundu A, Mitsakakis N, Elton-Marshall T, Wang W, Hill S, Bondy SJ, Hamilton H, Selby P, Schwartz R, Chaiton MO.
PMID: 34452986
Tob Control. 2021 Aug 27; doi: 10.1136/tobaccocontrol-2020-056438. Epub 2021 Aug 27.

OBJECTIVE: Identify and review the body of tobacco research literature that self-identified as using machine learning (ML) in the analysis.DATA SOURCES: MEDLINE, EMABSE, PubMed, CINAHL Plus, APA PsycINFO and IEEE Xplore databases were searched up to September 2020. Studies...

Cite
Fu R, Kundu A, Mitsakakis N, et al. Machine learning applications in tobacco research: a scoping review. Tob Control. 2021;doi: 10.1136/tobaccocontrol-2020-056438.
Fu, R., Kundu, A., Mitsakakis, N., Elton-Marshall, T., Wang, W., Hill, S., Bondy, S. J., Hamilton, H., Selby, P., Schwartz, R., & Chaiton, M. O. (2021). Machine learning applications in tobacco research: a scoping review. Tobacco control, . https://doi.org/10.1136/tobaccocontrol-2020-056438
Fu, Rui, et al. "Machine learning applications in tobacco research: a scoping review." Tobacco control vol. (2021). doi: https://doi.org/10.1136/tobaccocontrol-2020-056438
Fu R, Kundu A, Mitsakakis N, Elton-Marshall T, Wang W, Hill S, Bondy SJ, Hamilton H, Selby P, Schwartz R, Chaiton MO. Machine learning applications in tobacco research: a scoping review. Tob Control. 2021 Aug 27; doi: 10.1136/tobaccocontrol-2020-056438. Epub 2021 Aug 27. PMID: 34452986.
Copy Download .nbib Format: NLM
The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Rahmani N, Veldhuizen S, Wong B, Selby P, Zawertailo L.
PMID: 33984144
Nicotine Tob Res. 2021 Nov 05;23(12):2028-2036. doi: 10.1093/ntr/ntab096.

INTRODUCTION: The prevalence of light smoking has increased in North America; however, research on the effectiveness of current treatments in this subpopulation of smokers is limited. We compared quit outcomes between light (1-10 cigarettes per day [CPD]) versus heavier...

Cite
Rahmani N, Veldhuizen S, Wong B, et al. The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers. Nicotine Tob Res. 2021;23(12):2028-2036doi: 10.1093/ntr/ntab096.
Rahmani, N., Veldhuizen, S., Wong, B., Selby, P., & Zawertailo, L. (2021). The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 23(12), 2028-2036. https://doi.org/10.1093/ntr/ntab096
Rahmani, Noreen, et al. "The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers." Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco vol. 23,12 (2021): 2028-2036. doi: https://doi.org/10.1093/ntr/ntab096
Rahmani N, Veldhuizen S, Wong B, Selby P, Zawertailo L. The Effectiveness of Nicotine Replacement Therapy in Light Versus Heavier Smokers. Nicotine Tob Res. 2021 Nov 05;23(12):2028-2036. doi: 10.1093/ntr/ntab096. PMID: 33984144.
Copy Download .nbib Format: NLM
A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS).

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco

Kim J, Kambari Y, Taggar A, Quilty LC, Selby P, Caravaggio F, Ueno F, Song J, Pollock BG, Graff-Guerrero A, Gerretsen P.
PMID: 34788450
Nicotine Tob Res. 2021 Nov 12; doi: 10.1093/ntr/ntab235. Epub 2021 Nov 12.

INTRODUCTION: Impaired illness awareness or the inability to recognize that one has a dependence on nicotine may be a major barrier to seeking cessation treatment. To better understand the role of impaired illness awareness on treatment seeking behavior and...

Cite
Kim J, Kambari Y, Taggar A, et al. A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS). Nicotine Tob Res. 2021;doi: 10.1093/ntr/ntab235.
Kim, J., Kambari, Y., Taggar, A., Quilty, L. C., Selby, P., Caravaggio, F., Ueno, F., Song, J., Pollock, B. G., Graff-Guerrero, A., & Gerretsen, P. (2021). A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS). Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, . https://doi.org/10.1093/ntr/ntab235
Kim, Julia, et al. "A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS)." Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco vol. (2021). doi: https://doi.org/10.1093/ntr/ntab235
Kim J, Kambari Y, Taggar A, Quilty LC, Selby P, Caravaggio F, Ueno F, Song J, Pollock BG, Graff-Guerrero A, Gerretsen P. A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS). Nicotine Tob Res. 2021 Nov 12; doi: 10.1093/ntr/ntab235. Epub 2021 Nov 12. PMID: 34788450.
Copy Download .nbib Format: NLM
The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis.

Neuroscience and biobehavioral reviews

Fornaro M, Carvalho AF, De Prisco M, Mondin AM, Billeci M, Selby P, Iasevoli F, Berk M, Castle DJ, de Bartolomeis A.
PMID: 34838527
Neurosci Biobehav Rev. 2021 Nov 25;132:289-303. doi: 10.1016/j.neubiorev.2021.11.039. Epub 2021 Nov 25.

The prevalence, correlates, and management of tobacco use disorder (TUD) or nicotine dependence (ND) among people with severe mental illness (SMI), namely schizophrenia, bipolar disorder (BD), and major depressive disorder (MDD), remain unclear. Therefore, a systematic review and meta-analysis...

Cite
Fornaro M, Carvalho AF, De Prisco M, et al. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;132:289-303doi: 10.1016/j.neubiorev.2021.11.039.
Fornaro, M., Carvalho, A. F., De Prisco, M., Mondin, A. M., Billeci, M., Selby, P., Iasevoli, F., Berk, M., Castle, D. J., & de Bartolomeis, A. (2021). The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neuroscience and biobehavioral reviews, 132289-303. https://doi.org/10.1016/j.neubiorev.2021.11.039
Fornaro, Michele, et al. "The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis." Neuroscience and biobehavioral reviews vol. 132 (2021): 289-303. doi: https://doi.org/10.1016/j.neubiorev.2021.11.039
Fornaro M, Carvalho AF, De Prisco M, Mondin AM, Billeci M, Selby P, Iasevoli F, Berk M, Castle DJ, de Bartolomeis A. The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis. Neurosci Biobehav Rev. 2021 Nov 25;132:289-303. doi: 10.1016/j.neubiorev.2021.11.039. Epub 2021 Nov 25. PMID: 34838527.
Copy Download .nbib Format: NLM
Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report.

Journal of addiction medicine

Hauck TS, Rochon S, Bahra P, Selby P.
PMID: 33900229
J Addict Med. 2021 Apr 26; doi: 10.1097/ADM.0000000000000857. Epub 2021 Apr 26.

BACKGROUND: Novel psychoactive substances, such as designer benzodiazepines unapproved for therapeutic purposes, are an emerging concern worldwide. They have unknown or unpredictable pharmacological properties. Using a case example, we discuss the use of "Xanax bars," which now generally do...

Cite
Hauck TS, Rochon S, Bahra P, et al. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. J Addict Med. 2021;doi: 10.1097/ADM.0000000000000857.
Hauck, T. S., Rochon, S., Bahra, P., & Selby, P. (2021). Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. Journal of addiction medicine, . https://doi.org/10.1097/ADM.0000000000000857
Hauck, Tanya S, et al. "Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report." Journal of addiction medicine vol. (2021). doi: https://doi.org/10.1097/ADM.0000000000000857
Hauck TS, Rochon S, Bahra P, Selby P. Outpatient Treatment of Chronic Designer Benzodiazepine Use: A Case Report. J Addict Med. 2021 Apr 26; doi: 10.1097/ADM.0000000000000857. Epub 2021 Apr 26. PMID: 33900229.
Copy Download .nbib Format: NLM
Showing 73 to 77 of 77 entries